View Older Stories View More Recent Stories
-
MOSS Relaunches Signature 'Custom Made' Service, Redefining Accessible Tailoring
-
BHG Financial Closes a New ABS Transaction of $432 Million
-
IREN Limited (IREN) call put ratio 3.4 calls to 1 put into quarter results
-
Hormel Foods (HRL) call put ratio 1 call to 1.1 puts into quarter results
-
BMO Capital Reiterates Market Perform Rating on Meta Platforms Inc. (META), 'will face engagement questions and continued capex ROI concerns'
-
SentinelOne, Inc. (S) call put ratio 9.1 calls to 1 put with a focus on August 25 weekly calls into tquarter results
-
Evercore ISI comments on Cisco (CSCO) and SMCI partnership
-
William Blair on Palantir (PLTR): 'Tracker Indicates Maven Is Surging Toward a Billion-Dollar ARR'
-
Dollar Tree (DLTR) call put ratio 1 call to 1 put into quarter results
-
Dollar General (DG) call put ratio 1 call to 1.4 puts into quarter results
-
Best Buy (BBY) call put ratio 1 call to 1.3 puts into quarter results
-
Waystar unveils AI agents to automate healthcare billing tasks
-
Workday (WDAY) call put ratio 1.5 calls to 1 put into quarter results
-
Ulta Beauty (ULTA) call put ratio 1 call to 9 puts with a focus on September weekly 530 puts into quarter results
-
Meta agrees to pay $18 billion to settle US lawsuits over children's social media addiction
-
Affirm Holdings (AFRM) call put ratio 2.1 calls to 1 put into quarter results
-
Li Auto (LI) PT Lowered to $16 at US Tiger Securities
-
Burlington Stores (BURL) September 4 weekly 310, September 335, September 25 weekly 305, October 340 puts active into quarter results
-
Rubrik (RBRK) spreader of January 100 and 150 calls into quarter results
-
Autodesk (ADSK) call put ratio 1 call to 3.1 puts with a focus on September 4 weekly puts into quarter results
-
Banks Moving Forward With Global Stablecoin Consortium - WSJ
-
Synopsys (SNPS) call put ratio 2.1 calls to 1 put into quarter results
-
TD Cowen Reiterates Buy Rating on Biohaven Pharma (BHVN)
-
NVIDIA (NVDA) call put ratio 1.6 calls to 1 put into quarter results
-
CrowdStrike Holdings Inc. (CRWD) call put ratio 1.7 calls to 1 put into quarter results
-
Keysight EDA software cuts AttoTude IC design cycles by 50%
-
Salesforce (CRM) call put ratio 1 call to 1.9 puts into quarter results
-
Benetech Names New Hampshire Vision Specialist Inaugural Winner of Educator Impact Award
-
TriSummit Utilities Inc. Closes $200 Million Medium-Term Note Offering
-
Agilent Technologies (A) call put ratio 1.7 calls to 1 put into quarter results
-
HP Inc. (HPQ) call put ratio 1 call to 1.1 puts into quarter results
-
Star Diamond SEO Publishes Proprietary 5C Framework for Small Business Search Visibility
-
Okta, Inc. (OKTA) call put ratio 1 call to 1.6 puts into quarter results
-
Atlas Designs BCIN Inc. Expands Into Basement Construction, Adding Build Services to Its Toronto and GTA Permit Design Practice
-
Jeremy Hayes Joins Dr Ted Injury Law Legal Team
-
China's Moonshot in talks with Microsoft, Amazon, Google over K3 revenue sharing - Reuters
-
How Entrepreneurial Is Your Province
-
FDA approves Revolution Medicines pancreatic cancer drug Rasonque
-
Increasing unusual put volume: DKS FRVO PLAB CMPS ANF CARR SPYM KSS BURL SMMT A SMTC INTU MDLZ BX KDP TTMI ZM
-
Increasing unusual call volume: DKS CCCC IMPP VERA EMBJ GMAB DUST BCS KHC SOLZ SN ANF AI PLAB
-
US says it disrupted Chinese hacking operation targeting government agencies
-
Increasing unusual option volume: CCCC DKS IMPP VERA GMAB EMBJ SN PLAB ANF DUST SOLZ KHC AI BCS
-
Popular stocks: MU AMD SPCX INTC SOFI PLTR KHC MSTR ORCL AVGO DKS BAC MRNA
-
Active options: INTC SOFI PLTR AMZN KHC MSTR ORCL GOOGL AVGO DKS BAC MRNA
-
Active options: TSLA META NVDA AAPL MSFT MU AMD SPCX
-
ATEX Resources Inc. (ATX) Opens the Market
-
Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
-
Evercore ISI on Meta Platforms Inc. (META): 'The risk and the issue may not be fully resolved, but it appears to be largely resolved'
-
Hunt's Growth Story Earns Third Consecutive Inc. 5000 Recognition
-
Biohaven Pharma (BHVN) PT Lowered to $30 at Raymond James
